Compare SOTK & NSPR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SOTK | NSPR |
|---|---|---|
| Founded | 1975 | 2005 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.8M | 77.5M |
| IPO Year | 1995 | 2009 |
| Metric | SOTK | NSPR |
|---|---|---|
| Price | $4.08 | $1.64 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 1 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 29.0K | 17.0K |
| Earning Date | 01-01-0001 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 7.32 |
| EPS | ★ 0.08 | N/A |
| Revenue | ★ $20,504,381.00 | $2,310,000.00 |
| Revenue This Year | $4.02 | $22.91 |
| Revenue Next Year | $10.95 | $72.30 |
| P/E Ratio | $53.00 | ★ N/A |
| Revenue Growth | ★ 4.08 | N/A |
| 52 Week Low | $3.23 | $1.51 |
| 52 Week High | $5.15 | $3.34 |
| Indicator | SOTK | NSPR |
|---|---|---|
| Relative Strength Index (RSI) | 45.07 | 40.76 |
| Support Level | $4.03 | $1.62 |
| Resistance Level | $4.32 | $2.51 |
| Average True Range (ATR) | 0.23 | 0.11 |
| MACD | -0.00 | -0.01 |
| Stochastic Oscillator | 8.78 | 17.12 |
Sono-Tek Corp design and manufacture of ultrasonic coating systems for applying precise, thin film coatings to add functional properties, protect or strengthen surfaces on parts and components for the microelectronics/electronics, alternative energy, medical, industrial and emerging research & development/other markets. The company design and manufacture custom-engineered ultrasonic coating systems incorporating its patented technology, in combination with strong applications engineering knowledge, to assist its customers in achieving their desired coating solutions.
InspireMD Inc is a United States based medical device company. It is focused on the development and commercialization of proprietary MicroNet stent platform technology for the treatment of complex vascular and coronary disease. The products of the company are the CGuard carotid Embolic Prevention System (CGuard EPS) and the MGuard Prime Embolic Protection System (MGuard Prime EPS). It generates the majority of the revenue from the sales of CGuard EPS which combines MicroNet and a self-expandable nitinol stent in a single device for use in carotid artery applications. The group operates in Italy, Germany, Russia and other countries.